SlideShare une entreprise Scribd logo
1  sur  63
Télécharger pour lire hors ligne
TWIN PREGNANCY
INTRODUCTION
• 1% of all pregnancies
• Over 97% of all multiple pregnancies are twin
pregnancies (Joseph 1998).
• Associated with increased perinatal mortality & morbidity
• Results from ovulation & fertilization of > 1 oocyte OR
splitting of 1 embryonic mass to form 2 genetically
identical fetus
• Since 1970, the prevalence of multiple births has been
increasing because of more widespread use of ART.
INCIDENCE
Hellin’s law
Twin 1 : 80
Triplets 1 : 802
Quadruplets 1:803
Quniplets 1:804
Frequency of twins : highest – black race,
lowest – orientals
Increase with maternal age and parity
The chances to get twin 2x  if conception <1
month after discontinuation of oral
contraceptives
Increase with ART
TERMS
Zygosity refers to the type of conception
Two thirds of all twins are dizygotic.
Chorionicity denotes the type of
placentation.
*Chorionicity rather than zygosity
determines outcome.
TWINS
DIZYGOTIC
2/3
MONOZYGOTIC
1/3
Monochorionic monoamniotic <1%
Monochorionic diamniotic -75%
Dichorionic diamniotic -25%
Dichorionic
Diamniotic
Twin pregnancy update hospital segamat
DIZYGOTIC
• Fertilization of 2 separate ova
DIZYGOTIC
• incidence of dizygotic twins varies with
–ethnic group - up to 5 times higher in
certain parts of Africa and half as high in
parts of Asia
–maternal age - 3 in 1000 births in women
younger than 20,14 in 1000 births in
women aged 35-40 y
–Parity - 2% after four pregnancies
–method of conception - 20% with ovulation
induction.
MONOZYGOTIC
• Also known as identical twins.
• 1/3 of twin.
• Fertilization of single ovum
• Similar sex
• Identical in every way including HLA genes
• Not genetically determined
• Its prevalence 1/250
THE OUTCOME OF TWINNING PROCESS DEPENDS ON
WHEN THE DIVISION OCCUR
Monoamniotic
monochorionic
Diamniotic
monochorionic
Diamniotic dichorionic
9 – 12 days 4 – 8 days 0 – 3 days
< 1 % 75 % 25 %
After amnion and
chorion are formed
After chorion formed
Before amnion formed
Before amnion and
chorion formed
*Division after 13 days  Conjoined twin
Twin pregnancy update hospital segamat
ZYGOSITY AND CHORIONICITY
• Zygosity - determined by DNA fingerprinting.
– require an invasive procedure – amniocentesis,
chorionic villus sampling or cordocentesis
• Chorionicity - determined by USS (fetal gender, number of
placentas and characteristics of the membrane between the
two amniotic sacs).
– Different-sex twins =dizygotic and dichorionic,
– but in 2/3 of twin pregnancies the fetuses same sex and
these may be either monozygotic or dizygotic.
– Two separate placentas=dichorionic
– but, iftwo placentas are adjacent to each other and
therefore difficult to distinguish between dichorionic-
fused and monochorionic placentas.
ZYGOSITY AND CHORIONICITY
• The best way to determine chorionicity
 ultrasound examination at 10-14 weeks of
gestation
• Lambda sign-Dichorionic
• T-sign - Monochorionic
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
DIAGNOSIS OF MULTIPLE PREGNANCY
History : h/o IVF, taking ovulation inducing drugs
Symptoms
 Early pregnancy : excessive nausea, vomiting, Abnormal
bleeding
 Mid pregnancy : excessive weight gain, uterus larger than date
 Late pregnancy : pressure symptoms – dyspnea, dyspepsia
Signs :
 Anemia, edema, high BP, abnormal weight gain
 Uterus larger than date
 Multiple fetal poles felt
 2 distinct FH heard
Ix : confirm by Ultrasound
 Detect 99% of multiple gestation before 26 weeks
 Confirms fetal viability
 Diagnose type
 Confirm fetal numbers.
Patient care
Dichorionic twins
• Ultrasound at 10–14 weeks: (a)
viability; (b) chorionicity; (c) NT:
aneuploidy
• Structural anomaly scan at 20–22
weeks.
• Serial fetal growth scans e.g 24,
28, 32 and then two- to four-
weekly.
• 34–36 weeks: discussion of mode
of delivery and intrapartum care.
• Elective delivery at 37–38
completed weeks. Some by
40weeks
• Postnatal advice and support
(hospital- and community-based)
to include breastfeeding and
contraceptive advice
Monochorionic twins
• Ultrasound at 10–14 weeks: (a)
viability; (b) chorionicity; (c) NT:
aneuploidy/TTTS
• Ultrasound surveillance for TTTS
and discordant growth: at 16
weeks and then two-weekly.
• Structural anomaly scan at 20–22
weeks (including fetal ECHO).
• Fetal growth scans at two-weekly
intervals until delivery.
• 32–34 weeks: discussion of mode
of delivery and intrapartum care.
• Elective delivery at 36–37
completed weeks (if
uncomplicated).
• Postnatal advice and support
(hospital- and community-based)
to include breastfeeding and
contraceptive advice.
At what age should genetic testing be offered to a
mother with dichorionic and monochorionic
twins?
• All women carrying twin pregnancies should be
referred for counselling to a centre for the
consideration of invasive testing at age 32.
• The counselling must be individualized and the
final decision must be taken by the parents
since the risk of amniocentesis is uncertain in
twin gestation.
―The chance of a 32 year old woman who carries
twins of unknown zygosity having at least one child
with Down syndrome is equivalent to the risks of a
35 year old with a singleton pregnancy.‖
METHODS AVAILABLE FOR GENETIC SCREENING
IN TWIN PREGNANCIES
• Biochemical screening for aneuploidy is not
recommended in twins.
• Maternal serum alpha fetoprotein (MS-AFP) is
useful for detection of open neural tube and other
birth defects.
• Evidence is promising that nuchal translucency
(NT) screening is useful for identifying twin
pregnancies at high risk of aneuploidy.
• The fetal loss rates with invasive testing
(amniocentesis and chorionic villus sampling
(CVS)) in twins are unclear.
• Invasive testing should be offered to twins according
to the usual standard of care.
HOSPITAL BEDREST
• Randomized controlled trials and a meta-
analysis of hospital bedrest in twin
pregnancies have shown no reduction in
preterm birth or perinatal death.
• In uncomplicated twin pregnancies, hospital
rest may result in increased risk of very
preterm birth and maternal psychosocial
stress.
• In women with twin pregnancy at high risk
for preterm birth because of premature
cervical change prior to labour, there is no
evidence that hospital bedrest will reduce
the rate of preterm birth.
ACTIVITY RESTRICTION/WORK LEAVE
• Restriction of activity level and the
recommendation to stop work is commonly
prescribed for women with twin pregnancies
as a preterm birth prevention strategy.
• This prophylactic intervention has only been
studied in a few observational trials with
historical or geographic controls with
conflicting results.
There is insufficient evidence to support
prophylactic activity restriction or work
leave in multiple gestation.
CERVICAL CERCLAGE
Prophylactic cervical cerclage has not been
shown to be effective in preventing preterm
birth in twin pregnancy in observational or
controlled trials.
There is moderate evidence against
routine prophylactic cervical cerclage in
multiple gestation. However, cerclage
may be indicated for the treatment of
incompetent cervix or other specific
circumstances.
PROPHYLACTIC TOCOLYTIC THERAPY
Most randomized controlled trials have failed
to show any benefit of prophylactic oral or
intravenous tocolytic therapy in multiple
gestation.
There is moderate evidence against
prophylactic tocolysis in the
management of multiple gestation, but it
may be indicated on other grounds.
Is there a role for routine clinical cervical
assessment in
multiple gestation?
• Despite the lack of precision, clinical cervical
assessment appears to be safe and may be effective
in monitoring twin gestations, if transvaginal
ultrasound is not available or determined to be too
expensive.
• However, compared to transvaginal sonography,
digital examination is more subjective and less
reproducible.
There is good evidence that premature cervical
change by digital examination predicts preterm
birth in twins.
Since there are no well designed intervention trials
available,the role of sonographic clinical cervical
Is home uterine activity monitoring useful in
predicting
preterm birth in twin pregnancy?
Although home uterine activity monitoring may be
helpful in identifying women at increased risk of
preterm labour before advanced cervical dilation
occurs, this information has not resulted in
reduction in the incidence of preterm labour,
advanced cervical dilation at presentation or
preterm birth in well-controlled randomized
controlled trials.
*There is moderate evidence against home
uterine activity monitoring in multiple
gestation.
Does the measurement of fetal fibronectin predict
preterm birth in twin pregnancy?
Data from prospective longitudinal studies suggests that a
positive
fetal fibronectin test has a very high negative predictive
value for the prediction of preterm birth in asymptomatic
patients. The positive predictive value for preterm labour and
delivery before 37 weeks is 60 percent for patients in preterm
labour, 45 percent in asymptomatic high-risk women, and 30
percent in asymptomatic low-risk women.
There is good evidence that the presence of cervicovaginal
fetal fibronectin in twins predicts preterm birth. Without
well designed intervention trials available, there is no basis
for incorporating fetal fibronectin screening into routine
prenatal management of multiple gestation.
MORTALITY AND MORBIDITY
• Multifetal pregnancies are high-risk pregnancies.
• fetal mortality rate for twins is 4 x the fetal mortality rate
for single births.
• neonatal mortality rate for twins is more than 5 x greater
than the neonatal mortality rate for single births.
• A high prevalence of low birth weight infants, due to
prematurity and intrauterine growth retardation (IUGR)
and their associated complications, contribute to this
problem.
Complications of Multiple Pregnancy
• preterm labor and birth
• pregnancy-induced hypertension/PE
– Women with multiple fetuses are more than three times as likely to
develop high blood pressure of pregnancy.
– This condition often develops earlier and is more severe than
pregnancy with one baby.
– It can also increase the chance of placental abruption (early
detachment of the placenta).
• anemia
– Anemia is more than twice as common in multiple pregnancies as in a
single birth.
• birth defects
– Multiple birth babies have about twice the risk of congenital (present
at birth) abnormalities including neural tube defects (such as spina
bifida), gastrointestinal, and heart abnormalities.
FETAL COMPLICATIONS
MATERNAL COMPLICATION
UNIQUE COMPLICATIONS
• Problems related to vascular
anastomosis between twins
• Single intrauterine demise
• Discordant twins
• Conjoined twins
• Cord entanglement
1. VASCULAR ANASTOMOSIS
Present only in monochorionic twin placentas.
Nearly 100% of monochorionic twin placentas have vascular
anastomoses,but there are marked variations in the
number ,size, and direction.
2 patterns of vascular anastomosis
• twin-to-twin transfusionsyndrome (TTTS)
• acardiac twinning or twin reversed arterial perfusion (TRAPS)
Twin-to-twin transfusion syndrome
(TTTS)
• Features of TTTS are the result of hypoperfusion
of the donor twin and hyperperfusion of the
recipient twin.
• twin becomes hypovolemic and oliguric or anuric.
• Oligohydramnios develops in the amniotic sac of
the donor twin.
• Profound oligohydramnios can result in the stuck
twin phenomenon in which the twin appears in a
fixed position against the uterine wall.
• Ultrasonography may fail to visualize the fetal
bladder because of absent urine.
Twin pregnancy update hospital segamat
• Either twin can develop hydrops fetalis.
– The donor twin can become hydropic because of
anemia and high-output heart failure.
– The recipient twin can become hydropic because
of hypervolemia.
• The recipient twin can also develop
hypertension, hypertrophic
cardiomegaly, disseminated intravascular
coagulation, and hyperbilirubinemia after
birth.
Twin-to-twin transfusion syndrome
(TTTS)
• Severe TTTS has a 60-100% fetal or neonatal
mortality rate.
• Mild-to-moderate TTTS is frequently
associated with premature delivery.
• Fetal demise of one twin is associated with
neurologic sequelae in 25% of surviving twins.
• The more premature the twins are at birth,
the higher the incidence of postnatal
morbidity and mortality
Twin pregnancy update hospital segamat
TWIN REVERSED ARTERIAL PERFUSION
SEQUENCE (TRAPS)
• 1:35,000 pregnancies, 1% of monochorionic
• Large arterio-arterial anastomosis
• Perinatal mortality in the pump twin is 55%, due to
polyhydramnios and high-output cardiac failure
• An acardiac twin which received its blood supply via a
large arterio-arterial anastomosis from a normal ‘pump’
co-twin
• ~>result in absent or rudimentary development of the
• upper body structures
• Not all pregnancies with TRAP sequence require
invasive treatment and this appears to be dependent on:
• i) the relative size of the ‘acardiac’ twin to the pump
twin and
• ii) the presence of any cardiovascular impairment in
the ‘pump’ twin.
• Careful monitoring and ultrasound surveillance is
required
Twin pregnancy update hospital segamat
SUGGESTED TREATMENT IN
VASCULAR ANASTOMOSIS
• Amniotic septostomy
• Laser ablation
• Selective fetocide
• Serial amnioreduction
Treatment for established TTTS:
The frequency of ultrasound surveillance of fetal
health in severe cases of TTTS will depend on the
severity and intervention strategy.
Therapeutic options: These include:
i) no intervention ( survival 0—30%),
ii) amnioreduction 64 percent ( survival 64% overall,
74%
of at least one twin),
iii) laser photocoagulation (55% overall survival—73%
of
at least one twin),
iv) amniotic septostomy, 83 percent survival (12 cases
only).
SERIAL AMNIOREDUCTION
LASER ABLATION
2. SINGLE INTRAUTERINE DEMISE
• 2-6% of twins pregnancies
• Up to 25% in MC twin pregnancy
• Perinatal morbidity and mortality of the surviving co-
twin
19% perinatal death
24% having serious longterm sequelae
• Morbidity of surviving fetus depend on chorionicity
and consequences of prematurity
SINGLE FETAL DEATH
• After the single fetal death in a monochorionic pregnancy, the
risk to the surviving twin of death or neurological abnormality
is of the order of 12% and 18%, respectively.
• Damage to MC twins after the death of a co-twin is now
thought to be caused by acute haemodynamic changes around
the time of death, with the survivor essentially haemorrhaging
part of its circulating volume into the circulation of the dying
twin.
• This may cause transient or persistent hypotension and low
perfusion,leading to the risk of ischaemic organ damage,
notably but not exclusively, to the brain
• Single fetal death in a monochorionic pregnancy should be
referred and assessed in a regional fetal medicine centre.
3. DISCORDANT FETAL GROWTH
• Fetal growth differs slightly in twin gestations and twin specific charts
may be used to define the normal growth rate. Precision may also be
obtained by using sex and race specific charts.
• In clinical practice, however, these differences are small and singleton
growth curves may be used. Patterns of fetal growth are more important
than absolute measurements. Both must be interpreted in the light of
the clinical history, together with all the genetic and environmental
factors that may affect fetal growth.
The diagnosis of discordance has been based on the following:
• AC difference of 20 mm (sensitivity of 80%, specificity 85%, PPV= 62%)
• EFW based on bi-parietal diameter (BPD) and AC or AC and femur length
(FL) > 20 percent (sensitivity 25-55%)
Fetal weight difference = wt. of the larger - wt.of smaller
wt.of the larger twin
( >15-25% poor outcome )
• It has been shown that the risk of fetal death
begins to increase progressively when the
weight discordance exceeds 25%.
• Discordant fetal growth can be due to different
genetic growth potentials, structural anomaly of
one fetus, or an unfavourable placental
implantation.
• True discordance is an indicator for an increased
risk of IUGR, morbidity, and mortality for the
smaller twin.
• A risk for aneuploidy, anomaly or viral syndrome
affecting only one fetus must also be considered
when discordant growth is identified.
Management
US monitoring of growth within a twin pair = mainstay in
management .
The indication for delivery should take into consideration
of the fetal well-being, the gestational age and serial
growth velocity
4. CONJOINED TWIN
Rare complication of monoamniotic twining, with
an incidence of around 1: 55 000 pregnancies.
Accurate prenatal diagnosis is possible in the first
trimester and allows better counseling of the
parents regarding the management options.
Types :
Anterior (thoracopagus)
Posterior (pygopagus)
Cephalic (craniopagus)
Caudal (ischiopagus)
van den Brand(1994) ;diagnosis of conjoined twins
can frequently be made at mid pregnancy using
USG - careful evaluation of the point of
connection and organs involved
Twin pregnancy update hospital segamat
5. CORD ENTANGLEMENT
• Cord entanglement occurs in over 70% of MCMA twins and is
believed to be the major cause for sudden IUFD
• Ultrasound diagnosis of cord entanglement and close fetal
surveillance from 24 weeks onward, may help to improve
perinatal outcome.
• Because of the high perinatal mortality, prophylactic delivery by
caesarean section at 32 to 34 weeks is recommended.
PRESENTATION
• 40% of twins present as vertex/vertex,
• 35% as vertex/non-vertex,
• remaining 25% of twins present with the
leading twin in a non-vertex presentation at
birth .
• Blickstein 1987; Grisaru 2000
DELIVERY
• If the first twin presents as breech - - CS as
being safer for the babies.
• Although many clinicians choose caesarean
section when the first twin presents as a
breech,because of concern about
‘interlocking’, this complication is extremely
rare. Cohen et al.47 reported ‘interlocking’
occurring only once in 817 twin pregnancies
where the first twin was breech and the
second cephalic.
DELIVERY
• For twins presenting vertex/vertex, most clinicians
recommend planned VB (ACOG 2002; CDSR 1996).
• However, planned CS may benefit twins in which the first
twin is presenting vertex for a number of reasons.
• As many as 20% of vertex presenting second twins will
change presentation spontaneously after the first twin is
delivered (Houlihan 1996).
• A substantial number of those presenting vertex/vertex will
present with serious acute intrapartum problems following
the delivery of the first twin (for example, conversion to
transverse lie, cord prolapse, prolonged interval to delivery
of the second twin), which may lead to emergency CS,
perinatal death, and neonatal morbidity.
MANAGEMENT DURING LABOR
Basic Principles
The presence of 2 skilled obstetrics attendants for
labor and delivery
Anesthesiologist available
Neonatal care personnel sufficient for resuscitation of
the newborns
Portable US scanner
Reliable IV access
CTG with dual monitoring capacity
INTRAPARTUM MANAGEMENT OF TWIN
PREGNANCY
1st stage
Good intrapartum care : blood, IV access,
continuous FH monitoring, adequate analgesia
and LPC.
it is also preferable to have an USG in the delivery
suite to detect the FH, fetal lie and presentation
when needed.
Progress of labour should be closely monitored
with 2-4 hourly VE.
The criteria for diagnosing slow progress are the
same as in singletons.
In case of inefficient uterine contractions,
oxytocin augmentation can be used.
2nd stage
 An experienced obstetrician must be present during the 2nd
stage of labour.
 Following delivery of the first twin, syntometrine must NOT be
given as it might facilitate the premature placental separation
before the delivery of the second twin.
 The cord of the first twin should be clamped and divided as
usual.
 After delivery of the 1st twin, the obstetrician should ascertain
the lie and presentation of the 2nd twin, using USG if required.
 Once a Cx presentation is confirmed, the decent of the fetal
head is expected with re-establishment of uterine contractions.
 Oxytocin infusion should be commenced if uterine contractions
have failed to resume.
 Fetal heart rate should be continuously monitored.
 A twin-to-twin delivery interval of ≤ 30 minutes, after which
delivery should be expedited, since the risks of both acidosis
and second stage Caesarean section increase with the length of
this interval
If the second twin is in non-vertex presentation, the available
options include
 Assisted vaginal breech delivery or breech extraction,
 Internal podalic version following by breech extraction,
 ECV followed by vaginal cephalic delivery,
 Emergency LSCS
3rd stage
• increased risks of primary PPH.
• delivery of the shoulder of the 2nd twin, active
management of the third stage should ensue.
• Oxytocin infusion in addition is advised.
• The placentas should be examined as a routine to
confirm the chorionicity and amnionicity.
Indications for Caesarean Section
Elective
First twin non-cephalic
Conjoined twin
Monoamniotic twin
Placenta previa
Previous LSCS
IUGR in dichorionic twin
Congenital abnormality
Emergency
Fetal distress
Cord prolapse of 1st twin
Non progress of labor
Collision of both twins
2nd twin transverse after delivery of 1st twin
SPECIALIZED TWIN CLINICS/PREVENTION
PROGRAMMES
Multi-intervention preterm birth prevention
programmes for twin pregnancies have been
evaluated in several observational studies with
contemporary and/or historical controls. All studies
reviewed suggest reduction in preterm birth
rate, decreased perinatal mortality, and overall
improvement in perinatal outcome.
The evidence to support specialized clinics is of
insufficient quality to recommend that they be
part of routine clinical practice. Further
randomized controlled studies are needed to
validate the improved outcomes that have been
demonstrated in cohort studies.
THANK YOU

Contenu connexe

Tendances

Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy obgymgmcri
 
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancyFahad Zakwan
 
Multiple Pregnancy - Diagnosis ,Clinical Features & Complications
Multiple Pregnancy - Diagnosis ,Clinical Features & ComplicationsMultiple Pregnancy - Diagnosis ,Clinical Features & Complications
Multiple Pregnancy - Diagnosis ,Clinical Features & ComplicationsHari Dev
 
Active management of third stage labor
Active management of third stage laborActive management of third stage labor
Active management of third stage laborAbhilasha verma
 
induction of labor - A Clinical Case Discussion
induction of labor - A Clinical Case Discussioninduction of labor - A Clinical Case Discussion
induction of labor - A Clinical Case DiscussionAfiqi Fikri
 
Breech presentation
Breech presentationBreech presentation
Breech presentationraj kumar
 
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...Lifecare Centre
 
Pprom & prom
Pprom & promPprom & prom
Pprom & promsnich
 
Preterm labour
Preterm labourPreterm labour
Preterm labourPoly Begum
 

Tendances (20)

Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Ecv rcog2006
Ecv rcog2006Ecv rcog2006
Ecv rcog2006
 
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Vbac
VbacVbac
Vbac
 
Retained placenta
Retained placentaRetained placenta
Retained placenta
 
Multiple Pregnancy - Diagnosis ,Clinical Features & Complications
Multiple Pregnancy - Diagnosis ,Clinical Features & ComplicationsMultiple Pregnancy - Diagnosis ,Clinical Features & Complications
Multiple Pregnancy - Diagnosis ,Clinical Features & Complications
 
Retained placenta
Retained  placentaRetained  placenta
Retained placenta
 
Active management of third stage labor
Active management of third stage laborActive management of third stage labor
Active management of third stage labor
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
 
Preterm labor
Preterm laborPreterm labor
Preterm labor
 
induction of labor - A Clinical Case Discussion
induction of labor - A Clinical Case Discussioninduction of labor - A Clinical Case Discussion
induction of labor - A Clinical Case Discussion
 
Breech presentation
Breech presentationBreech presentation
Breech presentation
 
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...
INTRAUTERINE DEATH CME ON INDUCTION OF LABOUR ON 8TH NOVEMBER 2016, Dr sharda...
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Pprom & prom
Pprom & promPprom & prom
Pprom & prom
 
Genital tuberculosis
Genital tuberculosisGenital tuberculosis
Genital tuberculosis
 
Obg seminar
Obg seminarObg seminar
Obg seminar
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 

En vedette

Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancyAbino David
 
MCDA Twin Pregnancy
MCDA Twin PregnancyMCDA Twin Pregnancy
MCDA Twin Pregnancylimgengyan
 
Ultrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEUltrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEAboubakr Elnashar
 
Twin pregnancy....a journey.....
Twin pregnancy....a journey.....Twin pregnancy....a journey.....
Twin pregnancy....a journey.....Sameer Dikshit
 
Mestrual cycle
Mestrual cycleMestrual cycle
Mestrual cycleHI HI
 
Leadership Issues In Implementing Change
Leadership Issues In Implementing ChangeLeadership Issues In Implementing Change
Leadership Issues In Implementing ChangeQuality Safety Edge
 
Fibroid complicating pregnancy
Fibroid complicating pregnancyFibroid complicating pregnancy
Fibroid complicating pregnancyMadhava Manoj
 
Fetal anomaly archive advanced usg lounge
Fetal anomaly archive advanced usg loungeFetal anomaly archive advanced usg lounge
Fetal anomaly archive advanced usg loungeRitesh Mahajan
 
Multiple Gestations
Multiple GestationsMultiple Gestations
Multiple GestationsClinton Pong
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancyArya Anish
 
Management of hypertensive crisis in pregnancy
Management of hypertensive crisis in pregnancyManagement of hypertensive crisis in pregnancy
Management of hypertensive crisis in pregnancyKirtan Vyas
 
Cardiac diseases complicating pregnancy
Cardiac diseases complicating pregnancyCardiac diseases complicating pregnancy
Cardiac diseases complicating pregnancyancychacko89
 
Early pregnancy
Early pregnancyEarly pregnancy
Early pregnancyairwave12
 

En vedette (20)

Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Twin pregnancy
Twin pregnancyTwin pregnancy
Twin pregnancy
 
MCDA Twin Pregnancy
MCDA Twin PregnancyMCDA Twin Pregnancy
MCDA Twin Pregnancy
 
Ultrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEUltrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINE
 
Twin pregnancy sophia bano
Twin pregnancy sophia banoTwin pregnancy sophia bano
Twin pregnancy sophia bano
 
Twin pregnancy protocol
Twin pregnancy protocolTwin pregnancy protocol
Twin pregnancy protocol
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Twin pregnancy by Dr shagufta naz
Twin pregnancy by Dr shagufta nazTwin pregnancy by Dr shagufta naz
Twin pregnancy by Dr shagufta naz
 
Twin pregnancy....a journey.....
Twin pregnancy....a journey.....Twin pregnancy....a journey.....
Twin pregnancy....a journey.....
 
Mestrual cycle
Mestrual cycleMestrual cycle
Mestrual cycle
 
Leadership Issues In Implementing Change
Leadership Issues In Implementing ChangeLeadership Issues In Implementing Change
Leadership Issues In Implementing Change
 
Fibroid complicating pregnancy
Fibroid complicating pregnancyFibroid complicating pregnancy
Fibroid complicating pregnancy
 
Fetal anomaly archive advanced usg lounge
Fetal anomaly archive advanced usg loungeFetal anomaly archive advanced usg lounge
Fetal anomaly archive advanced usg lounge
 
Twins
TwinsTwins
Twins
 
Multiple Gestations
Multiple GestationsMultiple Gestations
Multiple Gestations
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
 
Hysteroscopy
HysteroscopyHysteroscopy
Hysteroscopy
 
Management of hypertensive crisis in pregnancy
Management of hypertensive crisis in pregnancyManagement of hypertensive crisis in pregnancy
Management of hypertensive crisis in pregnancy
 
Cardiac diseases complicating pregnancy
Cardiac diseases complicating pregnancyCardiac diseases complicating pregnancy
Cardiac diseases complicating pregnancy
 
Early pregnancy
Early pregnancyEarly pregnancy
Early pregnancy
 

Similaire à Twin pregnancy update hospital segamat

ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...Lifecare Centre
 
Multiple Gestation.pptx
Multiple Gestation.pptxMultiple Gestation.pptx
Multiple Gestation.pptxMDasan1
 
Multiple Pregnancy.pptx
Multiple Pregnancy.pptxMultiple Pregnancy.pptx
Multiple Pregnancy.pptxMyatNoeSuuKyi1
 
Preterm birth role of hyroxyprogesterone
Preterm birth   role of hyroxyprogesteronePreterm birth   role of hyroxyprogesterone
Preterm birth role of hyroxyprogesteroneDr. Sunita Chandra
 
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptx
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptxMULTIPLE PREGNANCY, obstetrics and Gynecologist.pptx
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptxMonikaKosre
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in InfertilitySujoy Dasgupta
 
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsiPrecautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsiLifecare Centre
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.pptSriSushmaNagasuri
 
Multifetal Pregnancy.pptx
Multifetal Pregnancy.pptxMultifetal Pregnancy.pptx
Multifetal Pregnancy.pptxSachin Sharma
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...鋒博 蔡
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...t7260678
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...t7260678
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...t7260678
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...鋒博 蔡
 

Similaire à Twin pregnancy update hospital segamat (20)

Twin pregnancy.pptx
Twin pregnancy.pptxTwin pregnancy.pptx
Twin pregnancy.pptx
 
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
 
Multiple Gestation.pptx
Multiple Gestation.pptxMultiple Gestation.pptx
Multiple Gestation.pptx
 
Lecture 10 Multifetal pregnancy
Lecture 10 Multifetal pregnancyLecture 10 Multifetal pregnancy
Lecture 10 Multifetal pregnancy
 
Twins utz
Twins utzTwins utz
Twins utz
 
Multiple Pregnancy.pptx
Multiple Pregnancy.pptxMultiple Pregnancy.pptx
Multiple Pregnancy.pptx
 
Preterm birth role of hyroxyprogesterone
Preterm birth   role of hyroxyprogesteronePreterm birth   role of hyroxyprogesterone
Preterm birth role of hyroxyprogesterone
 
Triplet pregnancy
Triplet pregnancyTriplet pregnancy
Triplet pregnancy
 
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptx
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptxMULTIPLE PREGNANCY, obstetrics and Gynecologist.pptx
MULTIPLE PREGNANCY, obstetrics and Gynecologist.pptx
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
 
Multiple pregnancy after art
Multiple pregnancy after artMultiple pregnancy after art
Multiple pregnancy after art
 
Twin gestation
Twin gestationTwin gestation
Twin gestation
 
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsiPrecautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
 
Multifetal Pregnancy.pptx
Multifetal Pregnancy.pptxMultifetal Pregnancy.pptx
Multifetal Pregnancy.pptx
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
 
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
Clinical manaement of in vitrofertilizatonwithpreimplantation geneticdiagnosi...
 

Plus de Dr Zharifhussein

Hiv in pregnancy by zharif
Hiv in pregnancy by zharifHiv in pregnancy by zharif
Hiv in pregnancy by zharifDr Zharifhussein
 
Early onset of neonatal group b streptococcus diseases zharif
Early onset of neonatal group b streptococcus diseases zharifEarly onset of neonatal group b streptococcus diseases zharif
Early onset of neonatal group b streptococcus diseases zharifDr Zharifhussein
 
Polycystic Ovarian syndrome
Polycystic Ovarian syndromePolycystic Ovarian syndrome
Polycystic Ovarian syndromeDr Zharifhussein
 
Update in obstetrics and gynecology 2 2012
Update in obstetrics and gynecology 2 2012Update in obstetrics and gynecology 2 2012
Update in obstetrics and gynecology 2 2012Dr Zharifhussein
 
Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Dr Zharifhussein
 
Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Dr Zharifhussein
 
Multiple pregnancy gynae segamat
Multiple pregnancy gynae segamatMultiple pregnancy gynae segamat
Multiple pregnancy gynae segamatDr Zharifhussein
 

Plus de Dr Zharifhussein (20)

Hiv in pregnancy by zharif
Hiv in pregnancy by zharifHiv in pregnancy by zharif
Hiv in pregnancy by zharif
 
Shoulder dystocia
Shoulder dystociaShoulder dystocia
Shoulder dystocia
 
Breech presentataion
Breech presentataionBreech presentataion
Breech presentataion
 
Early onset of neonatal group b streptococcus diseases zharif
Early onset of neonatal group b streptococcus diseases zharifEarly onset of neonatal group b streptococcus diseases zharif
Early onset of neonatal group b streptococcus diseases zharif
 
Post partum Haemorrhage
Post partum HaemorrhagePost partum Haemorrhage
Post partum Haemorrhage
 
Polycystic Ovarian syndrome
Polycystic Ovarian syndromePolycystic Ovarian syndrome
Polycystic Ovarian syndrome
 
Dr.nurul eclampsia
Dr.nurul   eclampsiaDr.nurul   eclampsia
Dr.nurul eclampsia
 
Update in obstetrics and gynecology 2 2012
Update in obstetrics and gynecology 2 2012Update in obstetrics and gynecology 2 2012
Update in obstetrics and gynecology 2 2012
 
Post partum haemorrhage
Post partum haemorrhage Post partum haemorrhage
Post partum haemorrhage
 
Post natal care update
Post natal care updatePost natal care update
Post natal care update
 
Post dates and induction
Post dates and inductionPost dates and induction
Post dates and induction
 
Pap smear and hpv vaccine
Pap smear and hpv vaccinePap smear and hpv vaccine
Pap smear and hpv vaccine
 
Menstrual disorders
Menstrual disordersMenstrual disorders
Menstrual disorders
 
Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012
 
Contraception junita
Contraception junitaContraception junita
Contraception junita
 
Ante partum haemorrhage
Ante partum haemorrhageAnte partum haemorrhage
Ante partum haemorrhage
 
Antenatal care.
Antenatal care.Antenatal care.
Antenatal care.
 
Anaemia in pregnancy
Anaemia in pregnancy Anaemia in pregnancy
Anaemia in pregnancy
 
Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012
 
Multiple pregnancy gynae segamat
Multiple pregnancy gynae segamatMultiple pregnancy gynae segamat
Multiple pregnancy gynae segamat
 

Dernier

Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingAnonymous
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfMedicoseAcademics
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).kishan singh tomar
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 

Dernier (20)

Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_Wellbeing
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdf
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 

Twin pregnancy update hospital segamat

  • 2. INTRODUCTION • 1% of all pregnancies • Over 97% of all multiple pregnancies are twin pregnancies (Joseph 1998). • Associated with increased perinatal mortality & morbidity • Results from ovulation & fertilization of > 1 oocyte OR splitting of 1 embryonic mass to form 2 genetically identical fetus • Since 1970, the prevalence of multiple births has been increasing because of more widespread use of ART.
  • 3. INCIDENCE Hellin’s law Twin 1 : 80 Triplets 1 : 802 Quadruplets 1:803 Quniplets 1:804 Frequency of twins : highest – black race, lowest – orientals Increase with maternal age and parity The chances to get twin 2x  if conception <1 month after discontinuation of oral contraceptives Increase with ART
  • 4. TERMS Zygosity refers to the type of conception Two thirds of all twins are dizygotic. Chorionicity denotes the type of placentation. *Chorionicity rather than zygosity determines outcome.
  • 5. TWINS DIZYGOTIC 2/3 MONOZYGOTIC 1/3 Monochorionic monoamniotic <1% Monochorionic diamniotic -75% Dichorionic diamniotic -25% Dichorionic Diamniotic
  • 8. DIZYGOTIC • incidence of dizygotic twins varies with –ethnic group - up to 5 times higher in certain parts of Africa and half as high in parts of Asia –maternal age - 3 in 1000 births in women younger than 20,14 in 1000 births in women aged 35-40 y –Parity - 2% after four pregnancies –method of conception - 20% with ovulation induction.
  • 9. MONOZYGOTIC • Also known as identical twins. • 1/3 of twin. • Fertilization of single ovum • Similar sex • Identical in every way including HLA genes • Not genetically determined • Its prevalence 1/250
  • 10. THE OUTCOME OF TWINNING PROCESS DEPENDS ON WHEN THE DIVISION OCCUR Monoamniotic monochorionic Diamniotic monochorionic Diamniotic dichorionic 9 – 12 days 4 – 8 days 0 – 3 days < 1 % 75 % 25 % After amnion and chorion are formed After chorion formed Before amnion formed Before amnion and chorion formed *Division after 13 days  Conjoined twin
  • 12. ZYGOSITY AND CHORIONICITY • Zygosity - determined by DNA fingerprinting. – require an invasive procedure – amniocentesis, chorionic villus sampling or cordocentesis • Chorionicity - determined by USS (fetal gender, number of placentas and characteristics of the membrane between the two amniotic sacs). – Different-sex twins =dizygotic and dichorionic, – but in 2/3 of twin pregnancies the fetuses same sex and these may be either monozygotic or dizygotic. – Two separate placentas=dichorionic – but, iftwo placentas are adjacent to each other and therefore difficult to distinguish between dichorionic- fused and monochorionic placentas.
  • 13. ZYGOSITY AND CHORIONICITY • The best way to determine chorionicity  ultrasound examination at 10-14 weeks of gestation • Lambda sign-Dichorionic • T-sign - Monochorionic
  • 17. DIAGNOSIS OF MULTIPLE PREGNANCY History : h/o IVF, taking ovulation inducing drugs Symptoms  Early pregnancy : excessive nausea, vomiting, Abnormal bleeding  Mid pregnancy : excessive weight gain, uterus larger than date  Late pregnancy : pressure symptoms – dyspnea, dyspepsia Signs :  Anemia, edema, high BP, abnormal weight gain  Uterus larger than date  Multiple fetal poles felt  2 distinct FH heard Ix : confirm by Ultrasound  Detect 99% of multiple gestation before 26 weeks  Confirms fetal viability  Diagnose type  Confirm fetal numbers.
  • 18. Patient care Dichorionic twins • Ultrasound at 10–14 weeks: (a) viability; (b) chorionicity; (c) NT: aneuploidy • Structural anomaly scan at 20–22 weeks. • Serial fetal growth scans e.g 24, 28, 32 and then two- to four- weekly. • 34–36 weeks: discussion of mode of delivery and intrapartum care. • Elective delivery at 37–38 completed weeks. Some by 40weeks • Postnatal advice and support (hospital- and community-based) to include breastfeeding and contraceptive advice Monochorionic twins • Ultrasound at 10–14 weeks: (a) viability; (b) chorionicity; (c) NT: aneuploidy/TTTS • Ultrasound surveillance for TTTS and discordant growth: at 16 weeks and then two-weekly. • Structural anomaly scan at 20–22 weeks (including fetal ECHO). • Fetal growth scans at two-weekly intervals until delivery. • 32–34 weeks: discussion of mode of delivery and intrapartum care. • Elective delivery at 36–37 completed weeks (if uncomplicated). • Postnatal advice and support (hospital- and community-based) to include breastfeeding and contraceptive advice.
  • 19. At what age should genetic testing be offered to a mother with dichorionic and monochorionic twins? • All women carrying twin pregnancies should be referred for counselling to a centre for the consideration of invasive testing at age 32. • The counselling must be individualized and the final decision must be taken by the parents since the risk of amniocentesis is uncertain in twin gestation. ―The chance of a 32 year old woman who carries twins of unknown zygosity having at least one child with Down syndrome is equivalent to the risks of a 35 year old with a singleton pregnancy.‖
  • 20. METHODS AVAILABLE FOR GENETIC SCREENING IN TWIN PREGNANCIES • Biochemical screening for aneuploidy is not recommended in twins. • Maternal serum alpha fetoprotein (MS-AFP) is useful for detection of open neural tube and other birth defects. • Evidence is promising that nuchal translucency (NT) screening is useful for identifying twin pregnancies at high risk of aneuploidy. • The fetal loss rates with invasive testing (amniocentesis and chorionic villus sampling (CVS)) in twins are unclear. • Invasive testing should be offered to twins according to the usual standard of care.
  • 21. HOSPITAL BEDREST • Randomized controlled trials and a meta- analysis of hospital bedrest in twin pregnancies have shown no reduction in preterm birth or perinatal death. • In uncomplicated twin pregnancies, hospital rest may result in increased risk of very preterm birth and maternal psychosocial stress. • In women with twin pregnancy at high risk for preterm birth because of premature cervical change prior to labour, there is no evidence that hospital bedrest will reduce the rate of preterm birth.
  • 22. ACTIVITY RESTRICTION/WORK LEAVE • Restriction of activity level and the recommendation to stop work is commonly prescribed for women with twin pregnancies as a preterm birth prevention strategy. • This prophylactic intervention has only been studied in a few observational trials with historical or geographic controls with conflicting results. There is insufficient evidence to support prophylactic activity restriction or work leave in multiple gestation.
  • 23. CERVICAL CERCLAGE Prophylactic cervical cerclage has not been shown to be effective in preventing preterm birth in twin pregnancy in observational or controlled trials. There is moderate evidence against routine prophylactic cervical cerclage in multiple gestation. However, cerclage may be indicated for the treatment of incompetent cervix or other specific circumstances.
  • 24. PROPHYLACTIC TOCOLYTIC THERAPY Most randomized controlled trials have failed to show any benefit of prophylactic oral or intravenous tocolytic therapy in multiple gestation. There is moderate evidence against prophylactic tocolysis in the management of multiple gestation, but it may be indicated on other grounds.
  • 25. Is there a role for routine clinical cervical assessment in multiple gestation? • Despite the lack of precision, clinical cervical assessment appears to be safe and may be effective in monitoring twin gestations, if transvaginal ultrasound is not available or determined to be too expensive. • However, compared to transvaginal sonography, digital examination is more subjective and less reproducible. There is good evidence that premature cervical change by digital examination predicts preterm birth in twins. Since there are no well designed intervention trials available,the role of sonographic clinical cervical
  • 26. Is home uterine activity monitoring useful in predicting preterm birth in twin pregnancy? Although home uterine activity monitoring may be helpful in identifying women at increased risk of preterm labour before advanced cervical dilation occurs, this information has not resulted in reduction in the incidence of preterm labour, advanced cervical dilation at presentation or preterm birth in well-controlled randomized controlled trials. *There is moderate evidence against home uterine activity monitoring in multiple gestation.
  • 27. Does the measurement of fetal fibronectin predict preterm birth in twin pregnancy? Data from prospective longitudinal studies suggests that a positive fetal fibronectin test has a very high negative predictive value for the prediction of preterm birth in asymptomatic patients. The positive predictive value for preterm labour and delivery before 37 weeks is 60 percent for patients in preterm labour, 45 percent in asymptomatic high-risk women, and 30 percent in asymptomatic low-risk women. There is good evidence that the presence of cervicovaginal fetal fibronectin in twins predicts preterm birth. Without well designed intervention trials available, there is no basis for incorporating fetal fibronectin screening into routine prenatal management of multiple gestation.
  • 28. MORTALITY AND MORBIDITY • Multifetal pregnancies are high-risk pregnancies. • fetal mortality rate for twins is 4 x the fetal mortality rate for single births. • neonatal mortality rate for twins is more than 5 x greater than the neonatal mortality rate for single births. • A high prevalence of low birth weight infants, due to prematurity and intrauterine growth retardation (IUGR) and their associated complications, contribute to this problem.
  • 29. Complications of Multiple Pregnancy • preterm labor and birth • pregnancy-induced hypertension/PE – Women with multiple fetuses are more than three times as likely to develop high blood pressure of pregnancy. – This condition often develops earlier and is more severe than pregnancy with one baby. – It can also increase the chance of placental abruption (early detachment of the placenta). • anemia – Anemia is more than twice as common in multiple pregnancies as in a single birth. • birth defects – Multiple birth babies have about twice the risk of congenital (present at birth) abnormalities including neural tube defects (such as spina bifida), gastrointestinal, and heart abnormalities.
  • 32. UNIQUE COMPLICATIONS • Problems related to vascular anastomosis between twins • Single intrauterine demise • Discordant twins • Conjoined twins • Cord entanglement
  • 33. 1. VASCULAR ANASTOMOSIS Present only in monochorionic twin placentas. Nearly 100% of monochorionic twin placentas have vascular anastomoses,but there are marked variations in the number ,size, and direction. 2 patterns of vascular anastomosis • twin-to-twin transfusionsyndrome (TTTS) • acardiac twinning or twin reversed arterial perfusion (TRAPS)
  • 34. Twin-to-twin transfusion syndrome (TTTS) • Features of TTTS are the result of hypoperfusion of the donor twin and hyperperfusion of the recipient twin. • twin becomes hypovolemic and oliguric or anuric. • Oligohydramnios develops in the amniotic sac of the donor twin. • Profound oligohydramnios can result in the stuck twin phenomenon in which the twin appears in a fixed position against the uterine wall. • Ultrasonography may fail to visualize the fetal bladder because of absent urine.
  • 36. • Either twin can develop hydrops fetalis. – The donor twin can become hydropic because of anemia and high-output heart failure. – The recipient twin can become hydropic because of hypervolemia. • The recipient twin can also develop hypertension, hypertrophic cardiomegaly, disseminated intravascular coagulation, and hyperbilirubinemia after birth.
  • 37. Twin-to-twin transfusion syndrome (TTTS) • Severe TTTS has a 60-100% fetal or neonatal mortality rate. • Mild-to-moderate TTTS is frequently associated with premature delivery. • Fetal demise of one twin is associated with neurologic sequelae in 25% of surviving twins. • The more premature the twins are at birth, the higher the incidence of postnatal morbidity and mortality
  • 39. TWIN REVERSED ARTERIAL PERFUSION SEQUENCE (TRAPS) • 1:35,000 pregnancies, 1% of monochorionic • Large arterio-arterial anastomosis • Perinatal mortality in the pump twin is 55%, due to polyhydramnios and high-output cardiac failure • An acardiac twin which received its blood supply via a large arterio-arterial anastomosis from a normal ‘pump’ co-twin • ~>result in absent or rudimentary development of the • upper body structures • Not all pregnancies with TRAP sequence require invasive treatment and this appears to be dependent on: • i) the relative size of the ‘acardiac’ twin to the pump twin and • ii) the presence of any cardiovascular impairment in the ‘pump’ twin. • Careful monitoring and ultrasound surveillance is required
  • 41. SUGGESTED TREATMENT IN VASCULAR ANASTOMOSIS • Amniotic septostomy • Laser ablation • Selective fetocide • Serial amnioreduction
  • 42. Treatment for established TTTS: The frequency of ultrasound surveillance of fetal health in severe cases of TTTS will depend on the severity and intervention strategy. Therapeutic options: These include: i) no intervention ( survival 0—30%), ii) amnioreduction 64 percent ( survival 64% overall, 74% of at least one twin), iii) laser photocoagulation (55% overall survival—73% of at least one twin), iv) amniotic septostomy, 83 percent survival (12 cases only).
  • 45. 2. SINGLE INTRAUTERINE DEMISE • 2-6% of twins pregnancies • Up to 25% in MC twin pregnancy • Perinatal morbidity and mortality of the surviving co- twin 19% perinatal death 24% having serious longterm sequelae • Morbidity of surviving fetus depend on chorionicity and consequences of prematurity
  • 46. SINGLE FETAL DEATH • After the single fetal death in a monochorionic pregnancy, the risk to the surviving twin of death or neurological abnormality is of the order of 12% and 18%, respectively. • Damage to MC twins after the death of a co-twin is now thought to be caused by acute haemodynamic changes around the time of death, with the survivor essentially haemorrhaging part of its circulating volume into the circulation of the dying twin. • This may cause transient or persistent hypotension and low perfusion,leading to the risk of ischaemic organ damage, notably but not exclusively, to the brain • Single fetal death in a monochorionic pregnancy should be referred and assessed in a regional fetal medicine centre.
  • 47. 3. DISCORDANT FETAL GROWTH • Fetal growth differs slightly in twin gestations and twin specific charts may be used to define the normal growth rate. Precision may also be obtained by using sex and race specific charts. • In clinical practice, however, these differences are small and singleton growth curves may be used. Patterns of fetal growth are more important than absolute measurements. Both must be interpreted in the light of the clinical history, together with all the genetic and environmental factors that may affect fetal growth. The diagnosis of discordance has been based on the following: • AC difference of 20 mm (sensitivity of 80%, specificity 85%, PPV= 62%) • EFW based on bi-parietal diameter (BPD) and AC or AC and femur length (FL) > 20 percent (sensitivity 25-55%) Fetal weight difference = wt. of the larger - wt.of smaller wt.of the larger twin ( >15-25% poor outcome )
  • 48. • It has been shown that the risk of fetal death begins to increase progressively when the weight discordance exceeds 25%. • Discordant fetal growth can be due to different genetic growth potentials, structural anomaly of one fetus, or an unfavourable placental implantation. • True discordance is an indicator for an increased risk of IUGR, morbidity, and mortality for the smaller twin. • A risk for aneuploidy, anomaly or viral syndrome affecting only one fetus must also be considered when discordant growth is identified.
  • 49. Management US monitoring of growth within a twin pair = mainstay in management . The indication for delivery should take into consideration of the fetal well-being, the gestational age and serial growth velocity
  • 50. 4. CONJOINED TWIN Rare complication of monoamniotic twining, with an incidence of around 1: 55 000 pregnancies. Accurate prenatal diagnosis is possible in the first trimester and allows better counseling of the parents regarding the management options. Types : Anterior (thoracopagus) Posterior (pygopagus) Cephalic (craniopagus) Caudal (ischiopagus) van den Brand(1994) ;diagnosis of conjoined twins can frequently be made at mid pregnancy using USG - careful evaluation of the point of connection and organs involved
  • 52. 5. CORD ENTANGLEMENT • Cord entanglement occurs in over 70% of MCMA twins and is believed to be the major cause for sudden IUFD • Ultrasound diagnosis of cord entanglement and close fetal surveillance from 24 weeks onward, may help to improve perinatal outcome. • Because of the high perinatal mortality, prophylactic delivery by caesarean section at 32 to 34 weeks is recommended.
  • 53. PRESENTATION • 40% of twins present as vertex/vertex, • 35% as vertex/non-vertex, • remaining 25% of twins present with the leading twin in a non-vertex presentation at birth . • Blickstein 1987; Grisaru 2000
  • 54. DELIVERY • If the first twin presents as breech - - CS as being safer for the babies. • Although many clinicians choose caesarean section when the first twin presents as a breech,because of concern about ‘interlocking’, this complication is extremely rare. Cohen et al.47 reported ‘interlocking’ occurring only once in 817 twin pregnancies where the first twin was breech and the second cephalic.
  • 55. DELIVERY • For twins presenting vertex/vertex, most clinicians recommend planned VB (ACOG 2002; CDSR 1996). • However, planned CS may benefit twins in which the first twin is presenting vertex for a number of reasons. • As many as 20% of vertex presenting second twins will change presentation spontaneously after the first twin is delivered (Houlihan 1996). • A substantial number of those presenting vertex/vertex will present with serious acute intrapartum problems following the delivery of the first twin (for example, conversion to transverse lie, cord prolapse, prolonged interval to delivery of the second twin), which may lead to emergency CS, perinatal death, and neonatal morbidity.
  • 56. MANAGEMENT DURING LABOR Basic Principles The presence of 2 skilled obstetrics attendants for labor and delivery Anesthesiologist available Neonatal care personnel sufficient for resuscitation of the newborns Portable US scanner Reliable IV access CTG with dual monitoring capacity
  • 57. INTRAPARTUM MANAGEMENT OF TWIN PREGNANCY 1st stage Good intrapartum care : blood, IV access, continuous FH monitoring, adequate analgesia and LPC. it is also preferable to have an USG in the delivery suite to detect the FH, fetal lie and presentation when needed. Progress of labour should be closely monitored with 2-4 hourly VE. The criteria for diagnosing slow progress are the same as in singletons. In case of inefficient uterine contractions, oxytocin augmentation can be used.
  • 58. 2nd stage  An experienced obstetrician must be present during the 2nd stage of labour.  Following delivery of the first twin, syntometrine must NOT be given as it might facilitate the premature placental separation before the delivery of the second twin.  The cord of the first twin should be clamped and divided as usual.  After delivery of the 1st twin, the obstetrician should ascertain the lie and presentation of the 2nd twin, using USG if required.  Once a Cx presentation is confirmed, the decent of the fetal head is expected with re-establishment of uterine contractions.  Oxytocin infusion should be commenced if uterine contractions have failed to resume.  Fetal heart rate should be continuously monitored.  A twin-to-twin delivery interval of ≤ 30 minutes, after which delivery should be expedited, since the risks of both acidosis and second stage Caesarean section increase with the length of this interval
  • 59. If the second twin is in non-vertex presentation, the available options include  Assisted vaginal breech delivery or breech extraction,  Internal podalic version following by breech extraction,  ECV followed by vaginal cephalic delivery,  Emergency LSCS
  • 60. 3rd stage • increased risks of primary PPH. • delivery of the shoulder of the 2nd twin, active management of the third stage should ensue. • Oxytocin infusion in addition is advised. • The placentas should be examined as a routine to confirm the chorionicity and amnionicity.
  • 61. Indications for Caesarean Section Elective First twin non-cephalic Conjoined twin Monoamniotic twin Placenta previa Previous LSCS IUGR in dichorionic twin Congenital abnormality Emergency Fetal distress Cord prolapse of 1st twin Non progress of labor Collision of both twins 2nd twin transverse after delivery of 1st twin
  • 62. SPECIALIZED TWIN CLINICS/PREVENTION PROGRAMMES Multi-intervention preterm birth prevention programmes for twin pregnancies have been evaluated in several observational studies with contemporary and/or historical controls. All studies reviewed suggest reduction in preterm birth rate, decreased perinatal mortality, and overall improvement in perinatal outcome. The evidence to support specialized clinics is of insufficient quality to recommend that they be part of routine clinical practice. Further randomized controlled studies are needed to validate the improved outcomes that have been demonstrated in cohort studies.